Lanean...
Current and future landscape of PARPi resistance
PURPOSE OF THE REVIEW: To highlight relevant strategies to overcome PARP inhibitor resistance and present key clinical trials. RECENT FINDINGS: The use of PARP inhibition (PARPi) for frontline maintenance offers substantial clinical benefit in patients with homologous recombination-deficient tumors....
Gorde:
| Argitaratua izan da: | Curr Opin Obstet Gynecol |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2021
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7958870/ https://ncbi.nlm.nih.gov/pubmed/33315700 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/GCO.0000000000000678 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|